|
Main
|
|
Note: This record shows only the 20 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
|
Register:
|
ClinicalTrials.gov |
|
Last refreshed on:
|
17 October 2012 |
|
Main ID: |
NCT00485602 |
|
Date of registration:
|
12/06/2007 |
|
Primary sponsor: |
|
|
Public title:
|
Orthodontic Treatment With a Part-Time Wearing Esthetic Removable Appliance
|
|
Scientific title:
|
|
|
Date of first enrolment:
|
December 2007 |
|
Target sample size:
|
20 |
|
Recruitment status: |
Not yet recruiting |
|
URL:
|
http://clinicaltrials.gov/show/NCT00485602 |
|
Study type:
|
Interventional |
|
Study design:
|
Allocation: Non-Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment
|
|
|
Countries of recruitment
|
|
Israel
| | | | | | | |
|
Contacts
|
|
Name:
|
Arik Tzukert, DMD |
|
Address:
|
|
|
Telephone:
|
0097226776095 |
|
Email:
|
arik@hadassah.org.il |
|
Affiliation:
|
|
|
|
Name:
|
Meir Redlich, PhD DMD |
|
Address:
|
|
|
Telephone:
|
0097226776184 |
|
Email:
|
mredlich@zahav.net.il |
|
Affiliation:
|
|
|
|
Name:
|
Meir Redlich |
|
Address:
|
|
|
Telephone:
|
|
|
Email:
|
|
|
Affiliation:
|
Hadassah Medical Organization |
|
|
Key inclusion & exclusion criteria
|
Inclusion Criteria:
- mild to moderate class I malocclusion
- good general health
- good oral hygiene
Exclusion Criteria:
- bad cooperation
- any mental or health problem
- severe class I malocclusion, class II or class III malocclusion
Age minimum:
8 Years
Age maximum:
68 Years
Gender:
Both
|
|
Health Condition(s) or Problem(s) studied
|
|
Malocclusion
|
|
Intervention(s)
|
|
Procedure: orthodontic treatment with "Rafenalign" appliance
|
|
Primary Outcome(s)
|
|
study models
[Time Frame: every 2 appointments (8 weeks)]
|
|
Secondary Outcome(s)
|
|
occlusal photographs
[Time Frame: every 3 appointments (12 weeks)]
|
|
Secondary ID(s)
|
|
RAFENALIGN-HMO-CTIL
|
|
Source(s) of Monetary Support
|
|
Please refer to primary and secondary sponsors
|
|